Literature DB >> 15643523

Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease.

Ans Baeyens1, Rudy Van Den Broecke, Amin Makar, Hubert Thierens, Leo De Ridder, Anne Vral.   

Abstract

The age dependency of onset of the disease on chromosomal radiosensitivity of an unselected group of breast cancer patients (n=100) was investigated and compared to a group of healthy women (n=100). The chromosomal radiosensitivity was assessed with the G2 and the G0 micro-nucleus (MN) assay. For the G2 assay lymphocytes were irradiated in vitro with a dose of 0.4 Gy 60Co gamma-rays after 70 h incubation and chromatid breaks were scored in 50 metaphases. For the G0 MN assay lymphocytes were exposed in vitro to 3.5 Gy 60Co gamma-rays at low dose rate (LDR). 72 h post-irradiation cultures were arrested and micronuclei were scored in 1000 binucleate cells. The results demonstrated that the group of breast cancer patients was more radiosensitive than a population of healthy women and this with both the G2 and the G0 MN assay. Analyses of the G2 and MN response in different age groups of the breast cancer patients revealed no significant differences in mean G2 and MN scores and suggest that the age of onset of the disease has no effect on chromosomal radiosensitivity in unselected breast cancer patients. Correlations with different clinical parameters were also investigated.

Entities:  

Mesh:

Year:  2005        PMID: 15643523

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

1.  Mechanisms of the formation of radiation-induced chromosomal aberrations.

Authors:  Peter E Bryant; Andrew C Riches; Samantha Y A Terry
Journal:  Mutat Res       Date:  2010-03-27       Impact factor: 2.433

2.  Suppression of topoisomerase IIalpha expression and function in human cells decreases chromosomal radiosensitivity.

Authors:  Samantha Y A Terry; Andrew C Riches; Peter E Bryant
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

3.  Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case-control study.

Authors:  Li-E Wang; Chan H Han; Ping Xiong; Melissa L Bondy; Tse-Kuan Yu; Abenaa M Brewster; Sanjay Shete; Banu K Arun; Thomas A Buchholz; Qingyi Wei
Journal:  Breast Cancer Res Treat       Date:  2012-01-05       Impact factor: 4.872

Review 4.  Evaluating the effects of genetic variants of DNA repair genes using cytogenetic mutagen sensitivity approaches.

Authors:  Sherif Z Abdel-Rahman; Randa A El-Zein
Journal:  Biomarkers       Date:  2011-05-20       Impact factor: 2.658

5.  A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure.

Authors:  Petra Willems; Kim De Ruyck; Rudy Van den Broecke; Amin Makar; Gianpaolo Perletti; Hubert Thierens; Anne Vral
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-15       Impact factor: 4.553

Review 6.  Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis.

Authors:  F Cardinale; P Bruzzi; C Bolognesi
Journal:  Br J Cancer       Date:  2011-12-20       Impact factor: 7.640

7.  Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study.

Authors:  Nathan A Cannon; Puneeth Iyengar; Hak Choy; Robert Timmerman; Jeffrey Meyer
Journal:  BMC Cancer       Date:  2014-12-17       Impact factor: 4.430

8.  A role for topoisomerase II alpha in the formation of radiation-induced chromatid breaks.

Authors:  S Y A Terry; A C Riches; P E Bryant
Journal:  Br J Cancer       Date:  2008-07-29       Impact factor: 7.640

9.  Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition?

Authors:  K De Ruyck; V de Gelder; M Van Eijkeren; T Boterberg; W De Neve; A Vral; H Thierens
Journal:  Br J Cancer       Date:  2008-04-15       Impact factor: 7.640

10.  Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer?

Authors:  W Vogel; H Surowy
Journal:  Br J Cancer       Date:  2007-09-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.